RAY1225
The Safety, Tolerability and Pharmacokinetic Study of RAY1225
Guangdong Raynovent Biotech Co · Phase 1 · Completed · Enrollment 68
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| RAY1225(Part A) | n/r | n/r | n/r | n/r | n/r |
| Placebo (Part A) | n/r | n/r | n/r | n/r | n/r |
| RAY1225 (Part B) | n/r | n/r | n/r | n/r | n/r |
| Placebo (Part B) | n/r | n/r | n/r | n/r | n/r |
| RAY1225(Part C) | n/r | n/r | n/r | n/r | n/r |
| Placebo (Part C) | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.